Jarad M Martin
Overview
Explore the profile of Jarad M Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1349
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofman M, Kasivisvanathan V, Link E, Buteau J, Roberts M, Francis R, et al.
Eur Urol Oncol
. 2024 Nov;
PMID: 39613566
Background And Objective: There is uncertainty regarding the clinical significance of Ga-PSMA-11 positron emission tomography (PET) computed tomography (CT) findings in men with prostate cancer. In this prespecified objective of...
2.
Ong W, Romero T, Roy S, Nikitas J, Joseph D, Zapatero A, et al.
Eur Urol
. 2024 Sep;
87(1):49-57.
PMID: 39304428
Background And Objective: Time to testosterone recovery (TR) following androgen deprivation therapy (ADT) with gonadotropin-releasing hormone agonists varies widely. We evaluate TR kinetics and the oncological impact of an effective...
3.
Morrell S, Roder D, Currow D, Engel A, Hovey E, Lewis C, et al.
Front Oncol
. 2024 Sep;
14:1338754.
PMID: 39234396
Introduction: Population cancer registries record primary cancer incidence, mortality and survival for whole populations, but not more timely outcomes such as cancer recurrence, secondary cancers or other complications that disrupt...
4.
Wegener E, Sidhom M, Pryor D, Bucci J, Yeoh K, Richardson M, et al.
Eur Urol Oncol
. 2024 Feb;
7(5):1042-1050.
PMID: 38302321
Background And Objective: Despite the high efficacy of high-dose-rate brachytherapy boost (HDRB) in the management of prostate cancer (PC), use of this approach is declining. Similar dosimetry can be achieved...
5.
Nikitas J, Ong W, Carrier N, Romero T, Millar J, Steinberg M, et al.
Int J Radiat Oncol Biol Phys
. 2023 Dec;
119(3):826-831.
PMID: 38151191
Purpose: A suboptimal prostate-specific antigen (PSA) response to neoadjuvant androgen deprivation therapy (ADT) among men who go on to receive definitive radiation therapy for prostate cancer might suggest the existence...
6.
Roberts M, Conduit C, Davis I, Effeney R, Williams S, Martin J, et al.
BJU Int
. 2023 Aug;
133 Suppl 3:39-47.
PMID: 37604702
Background: Salvage radiation therapy (SRT) and surveillance for low-risk prostate-specific antigen (PSA) recurrence have competing risks and benefits. The efficacy of early SRT to the prostate bed with or without...
7.
Roberts M, Hruby G, Kneebone A, Martin J, Williams S, Frydenberg M, et al.
BJU Int
. 2023 Jun;
132(2):146-148.
PMID: 37303121
No abstract available.
8.
Wegener E, Samuels J, Sidhom M, Trada Y, Sridharan S, Dickson S, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046680
Prostate cancer (PC) is the most common malignancy in men. Internal radiotherapy (brachytherapy) has been used to treat PC successfully for over a century. In particular, there is level-one evidence...
9.
Martin J, Richardson M, Siva S, Cardoso M, Handmer M, Sidhom M
Lancet Oncol
. 2022 Dec;
23(12):e534-e543.
PMID: 36455582
Urinary toxicity is common following pelvic radiotherapy and can have a substantial negative effect on survivorship. Due to its prevalence and the increasing number of related clinical trials, localised prostate...
10.
Pryor D, Martin J, Millar J, Day H, Ong W, Skala M, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2129647.
PMID: 34724555
Importance: Randomized clinical trials in prostate cancer have reported noninferior outcomes for hypofractionated radiation therapy (HRT) compared with conventional RT (CRT); however, uptake of HRT across jurisdictions is variable. Objective:...